Prior Endocrine Therapy Impact on Abiraterone Acetate Clinical Efficacy in Metastatic Castration-resistant Prostate Cancer: Post-hoc Analysis of Randomised Phase 3 Studies (Q41841139)

From Wikidata
Jump to navigation Jump to search
scientific article published on 24 October 2015
edit
Language Label Description Also known as
English
Prior Endocrine Therapy Impact on Abiraterone Acetate Clinical Efficacy in Metastatic Castration-resistant Prostate Cancer: Post-hoc Analysis of Randomised Phase 3 Studies
scientific article published on 24 October 2015

    Statements

    Prior Endocrine Therapy Impact on Abiraterone Acetate Clinical Efficacy in Metastatic Castration-resistant Prostate Cancer: Post-hoc Analysis of Randomised Phase 3 Studies (English)
    1 reference
    Joaquim Bellmunt
    1 reference
    Thian Kheoh
    1 reference
    Margaret K Yu
    1 reference
    Matthew R Smith
    1 reference
    Eric J Small
    1 reference
    Peter F A Mulders
    1 reference
    Dana E Rathkopf
    1 reference
    Howard I Scher
    1 reference
    Ian D Davis
    1 reference
    Dirk Schrijvers
    1 reference
    Andrew Protheroe
    1 reference
    Arturo Molina
    1 reference
    Peter De Porre
    1 reference
    Thomas W Griffin
    1 reference
    Johann S de Bono
    1 reference
    Charles J Ryan
    1 reference
    Stéphane Oudard
    1 reference
    24 October 2015
    1 reference
    69
    1 reference
    924-932
    1 reference

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit